Company & Sponsor Intelligence
US Department of Veterans Affairs
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed6
Countries1
Therapeutic footprint
alzheimersdepressionpain_neuropathystroke
Indexed studies
NCT00645970Pain, Psychiatric Disorders, and Disability Among Veterans With and Without Polytrauma
pain_neuropathy · United StatesCOMPLETED
pain_neuropathy · United StatesCOMPLETED
NCT00678431Randomized Trial of a Nutritional Supplement in Alzheimer's Disease
alzheimers · United StatesPHASE3
alzheimers · United StatesPHASE3
NCT00252538Genetic and Biochemical Markers of Interferon-Induced Depression.
depression · United StatesCOMPLETED
depression · United StatesCOMPLETED
NCT00012974Telephone Administered Psychotherapy for the Treatment of Depression for Veterans in Rural Areas
depression · United StatesPHASE1,PHASE2
depression · United StatesPHASE1,PHASE2
NCT00636701Improving Rehabilitation by Magnetic Brain Stimulation
stroke · United StatesPHASE1
stroke · United StatesPHASE1
NCT00018733Biological Aspects of Depression and Antidepressant Drugs
depression · United StatesNA
depression · United StatesNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →